Eligibility statement for Erythropoietic protoporphyria, mild variant (11037): Erythropoietic protoporphyria, mild variant inclusion criteria (29354) - History of episodic photosensitivity; - No evidence of an alternative cause of photosensitivity; - Onset of symptoms >60 mins after sun exposure and/or atypical symptoms compared to classical EPP photosensitivity and/or resolution of symptoms <48 hours - Raised red cell free protoporphyrin concentration Erythropoietic protoporphyria, mild variant exclusion criteria (29354) - Normal red cell protoporphyrin concentration Prior genetic testing guidance (29354) - Results should have been reviewed for all genetic tests undertaken, including disease-relevant genes in exome sequencing data. The patient is not eligible if they have a molecular diagnosis for their condition. - Genetic testing should continue according to routine local practice for this phenotype regardless of recruitment to the project; results of these tests must be submitted via the ‘Genetic investigations’ section of the data capture tool to allow comparison of WGS with current standard testing. PLEASE NOTE: The sensitivity of WGS compared to current diagnostic genetic testing has not yet been established. It is therefore important that tests which are clinically indicated under local standard practice continue to be carried out. Erythropoietic protoporphyria, mild variant prior genetic testing genes (29354) Testing of the following genes should be carried out PRIOR TO RECRUITMENT where this is in line with current local practice: - FECH Closing statement (29354) These requirements will be kept under continual review during the main programme and may be subject to change.
Ellen McDonagh (Genomics England Curator)
Group: Other
Workplace: Other
John McGrath (King's College London)
Group: GeCIP domain
Workplace: Research lab
Aleš Maver (Clinical Institute of Medical Genetics)
Group: Other
Workplace: Other diagnostic lab
List | Entity | Reviews | Mode of inheritance | Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Green List (high evidence) |
ALAS2 |
2 reviews1 green |
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) |
Sources
Phenotypes
Tags |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Green List (high evidence) |
FECH |
2 reviews1 green |
BIALLELIC, autosomal or pseudoautosomal |
Sources
Phenotypes
Tags |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No list |
CLPX |
1 review1 red |
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted |
Sources
Phenotypes
Tags |
Reviewed on 29.01.16.